Long noncoding RNAs (lncRNAs) are pervasively transcribed in the genome, exhibit a
diverse range of biological functions, and exert effects through a variety of mechanisms. The …

Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related mortality worldwide.
Early detection of HCC enables patients to avail curative therapies that can improve patient …

Ferroptosis is potential to relieve drug resistance in hepatocellular carcinoma (HCC).
Glutathione peroxidase 4 (GPX4) is a critical modulator of ferroptosis. This study discussed …

Hepatocellular carcinoma (HCC) is the sixth highest-incidence cancer and the 4th most
deadly cancer all over the world, with a high fatality and low diagnostic rate. Nowadays …

Hepatocellular carcinoma (HCC) is one of the most common and deadly tumors worldwide.
Management of HCC depends on reliable biomarkers for screening, diagnosis, and …

The effective detection of biomarkers associated with hepatocellular carcinoma (HCC) is of
great importance. Golgi protein 73 (GP73), a serum biomarker of HCC, has better diagnostic …

Simple Summary Pancreatic cancer is the seventh leading cause of cancer related death
worldwide. In the United States, pancreatic cancer remains the fourth leading cause of …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death
worldwide. Due to the lack of potent diagnosis and prognosis biomarkers and effective …

Simple Summary Hepatocellular carcinoma is the major form of liver cancer; it has a high
incidence in the global population, and it is a leading cause of the world's cancer burden …

Simple Summary Liver cancer, mainly represented by hepatocellular carcinoma (HCC),
constitutes the current third leading cause of tumor-associated death worldwide. Therefore …